Abstract
Evidence has demonstrated that endocannabinoid and the CB1 receptors are involved in mood disease, as anxiety and defensive behavior. An endocannabinoid interaction with endogenous opioid and serotonin (5-HT) systems may also participate in defensive behavior responses. Some neural substrates have an important participation in tonic immobility defensive behavior response, and the hypothal…